3/25/2013 9:41:57 AM
LOUISVILLE, Ky. & RIDGEFIELD, Conn.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, and Boehringer Ingelheim Pharmaceuticals, Inc., a research-based, global pharmaceutical company, today announced a multi-year collaboration dedicated to improving health care and reducing costs for people affected by chronic obstructive pulmonary disease (COPD), cardiovascular disease, and other chronic disease states. The partnership will leverage the strategic strengths of both organizations to promote population health, initially focusing on the early identification of COPD and other chronic diseases. Humana and Boehringer Ingelheim will bring their combined health care and research expertise together with the goal of enhancing patient health while reducing overall health care costs.
comments powered by